Long-term stability and circadian variation in circulating levels of surfactant protein D

Immunobiology

Volumn 215, Issue 4, 2010, Pages 314-320

  Hoegh, Silje Vermedal ^a   Sorensen, Grith Lykke ^a   Tornoe, Ida ^a   Lottenburger, Tine ^a   Ytting, Henriette ^c   Nielsen, Hans Jørgen ^c   Junker, Peter ^b   Holmskov, Uffe ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Biomarker; Circadian variation; Collectin; Innate immune system; Physical exercise; Surfactant protein D

Indexed keywords

BIOLOGICAL MARKER; SURFACTANT PROTEIN D;

ADULT; ARTICLE; BLOOD SAMPLING; CIRCADIAN RHYTHM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN STABILITY; TIME;

ADULT; AGED; CIRCADIAN RHYTHM; EXERCISE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEIN STABILITY; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D;

EID: 77649191273     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2009.05.001     Document Type: Article

References (30)

1. Borron P.J., Crouch E.C., Lewis J.F., Wright J.R., Possmayer F., and Fraher L.J. Recombinant rat surfactant-associated protein D inhibits human T lymphocyte proliferation and IL-2 production. J. Immunol. 161 (1998) 4599-4603
2. Botas C., Poulain F., Akiyama J., Brown C., Allen L., Goerke J., Clements J., Carlson E., Gillespie A.M., Epstein C., and Hawgood S. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc. Natl. Acad. Sci. USA 95 (1998) 11869-11874
3. Clark H., Palaniyar N., Strong P., Edmondson J., Hawgood S., and Reid K.B. Surfactant protein D reduces alveolar macrophage apoptosis in vivo. J. Immunol. 169 (2002) 2892-2899
4. Clark H., and Reid K. The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysema. Arch. Dis. Child. 88 (2003) 981-984
5. Crouch E., Parghi D., Kuan S.F., and Persson A. Surfactant protein D: subcellular localization in nonciliated bronchiolar epithelial cells. Am. J. Physiol. 263 (1992) L60-L66
6. Cutolo M., and Straub R.H. Circadian rhythms in arthritis: hormonal effects on the immune/inflammatory reaction. Autoimmun. Rev. 7 (2008) 223-228
7. Dulkerian S.J., Gonzales L.W., Ning Y., and Ballard P.L. Regulation of surfactant protein D in human fetal lung. Am. J. Respir. Cell Mol. Biol. 15 (1996) 781-786
8. Hartl D., and Griese M. Surfactant protein D in human lung diseases. Eur. J. Clin. Invest. 36 (2006) 423-435
9. Haus E., and Smolensky M.H. Biologic rhythms in the immune system. Chronobiol. Int. 16 (1999) 581-622
10. Hoegh S.V., Lindegaard H.M., Sorensen G.L., Hoj A., Bendixen C., Junker P., and Holmskov U. Circulating surfactant protein D is decreased in early rheumatoid arthritis: a 1-year prospective study. Scand. J. Immunol. 67 (2008) 71-76
11. Korfhagen T.R., Sheftelyevich V., Burhans M.S., Bruno M.D., Ross G.F., Wert S.E., Stahlman M.T., Jobe A.H., Ikegami M., Whitsett J.A., and Fisher J.H. Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J. Biol. Chem. 273 (1998) 28438-28443
12. Leth-Larsen R., Nordenbaek C., Tornoe I., Moeller V., Schlosser A., Koch C., Teisner B., Junker P., and Holmskov U. Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumonia. Clin. Immunol. 108 (2003) 29-37
13. Lomas, D.A., Silverman, E.K., Edwards, L.D., Locantore, N.W., Miller, B.E., Horstman, D.H., Tal-Singer, R., 2009. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur. Respir. J.
14. Madsen J., Kliem A., Tornoe I., Skjodt K., Koch C., and Holmskov U. Localization of lung surfactant protein D on mucosal surfaces in human tissues. J. Immunol. 164 (2000) 5866-5870
15. Miyata M., Sakuma F., Fukaya E., Kobayashi H., Rai T., Saito H., Kasukawa R., and Suzuki S. Detection and monitoring of methotrexate-associated lung injury using serum markers KL-6 and SP-D in rheumatoid arthritis. Intern. Med. 41 (2002) 467-473
16. Nanson C.J., Burgess J.L., Robin M., and Bernard A.M. Exercise alters serum pneumoprotein concentrations. Respir. Physiol. 127 (2001) 259-265
17. Pedersen B.K., and Hoffman-Goetz L. Exercise and the immune system: regulation, integration, and adaptation. Physiol. Rev. 80 (2000) 1055-1081
18. Petrovsky N., and Harrison L.C. The chronobiology of human cytokine production. Int. Rev. Immunol. 16 (1998) 635-649
19. Sin D.D., Leung R., Gan W.Q., and Man S.P. Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study. BMC Pulm. Med. 7 (2007) 13
20. Sin D.D., Man S.F., Marciniuk D.D., Ford G., FitzGerald M., Wong E., York E., Mainra R.R., Ramesh W., Melenka L.S., et al. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 177 (2008) 1207-1214
21. Sorensen G.L., Hjelmborg J.B., Kyvik K.O., Fenger M., Hoj A., Bendixen C., Sorensen T.I., and Holmskov U. Genetic and environmental influences of surfactant protein D serum levels. Am. J. Physiol. Lung Cell Mol. Physiol. 290 (2006) L1010-L1017
22. Sorensen G.L., Husby S., and Holmskov U. Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology 212 (2007) 381-416
23. Sorensen G.L., Madsen J., Kejling K., Tornoe I., Nielsen O., Townsend P., Poulain F., Nielsen C.H., Reid K.B., Hawgood S., et al. Surfactant protein D is proatherogenic in mice. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H2286-H2294
24. Umetani K., Abe M., Kawabata K., Iida T., Kohno I., Sawanobori T., and Kugiyama K. SP-D as a marker of amiodarone-induced pulmonary toxicity. Intern. Med. 41 (2002) 709-712
25. Vandivier R.W., Ogden C.A., Fadok V.A., Hoffmann P.R., Brown K.K., Botto M., Walport M.J., Fisher J.H., Henson P.M., and Greene K.E. Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J. Immunol. 169 (2002) 3978-3986
26. Voorhout W.F., Veenendaal T., Kuroki Y., Ogasawara Y., van Golde L.M., and Geuze H.J. Immunocytochemical localization of surfactant protein D (SP-D) in type II cells, Clara cells, and alveolar macrophages of rat lung. J. Histochem. Cytochem. 40 (1992) 1589-1597
27. Wang J.Y., Shieh C.C., You P.F., Lei H.Y., and Reid K.B. Inhibitory effect of pulmonary surfactant proteins A and D on allergen-induced lymphocyte proliferation and histamine release in children with asthma. Am. J. Respir. Crit. Care Med. 158 (1998) 510-518
28. Wang J.Y., Yeh T.F., Lin Y.C., Miyamura K., Holmskov U., and Reid K.B. Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome. Thorax 51 (1996) 907-913
29. Wert S.E., Yoshida M., LeVine A.M., Ikegami M., Jones T., Ross G.F., Fisher J.H., Korfhagen T.R., and Whitsett J.A. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc. Natl. Acad. Sci. USA 97 (2000) 5972-5977
30. Ytting H., Christensen I.J., Thiel S., Jensenius J.C., Svendsen M.N., Nielsen L., Lottenburger T., and Nielsen H.J. Biological variation in circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease-2 and the influence of age, gender and physical exercise. Scand. J. Immunol. 66 (2007) 458-464